Vertex One Asset Management’s Pfizer PFE Stock Holding History

Vertex One Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-377,416	Closed	-$11M	–	116
2013 Q4	$11M	Sell	377,416 -27,194	-7%	-$791K	1.59%	19
2013 Q3	$11M	Sell	404,610 -207,453	-34%	-$5.64M	1.49%	24
2013 Q2	$16.3M	Buy	+612,063	New	+$16.9M	2.81%	8

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vertex One Asset Management's PFE Position: Q1 2014 in Review

Vertex One Asset Management sold out of Pfizer (PFE) in Q1 2014, closing a stake of 377,416 shares — an estimated $11M sold.

Vertex One Asset Management first reported a position in PFE in Q2 2013 and held it in 3 quarters. The position peaked at $16.3M in Q2 2013. 1,780 funds tracked by Wall St. Rank hold PFE as of Q1 2014.

Vertex One Asset Management reported no remaining Pfizer position as of Q1 2014 after selling out during the quarter.
Vertex One Asset Management sold 377,416 Pfizer shares in Q1 2014, an estimated $11M.
Vertex One Asset Management first reported a position in Pfizer in Q2 2013 and held it in 3 quarters.
Vertex One Asset Management's Pfizer position peaked at $16.3M in Q2 2013.
1,780 funds tracked by Wall St. Rank held Pfizer as of Q1 2014.

Based on Vertex One Asset Management's 13F filing for Q1 2014, filed 15 May 2014.